Study on Bovine Trypanosomosis and Associated Risk Factors in Chora District of Oromia Region, Ethiopia
Clinical Research and Clinical Trials · 2020
DOI: 10.31579/2693-4779/016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research and Clinical Trials, 2020. Verfasst von Alemitu Adisu.
Abstract (Originalsprache)
Bovine Trypanosomosis is one of the most parsimoniously challenging diseases in influencing mammals like cattle and it is a grave haemoprotozoan disease triggered by different species of unicellular eukaryotic parasite of the genus trypanosome. This study was conducted to assess the prevalence of bovine trypanosomosis, and the influence of associated risk factors on cattle reared in Chora district of Buno Bedele Zone. A Blood sample was collected from a total of 401 cattle of age ranges from 1 to 6 years. The presence of parasites from sampled blood was examined using a method of Buffy Coat Technique and a technique of Giemsa-stained thin blood films was used to identify the existing trypanosome species in the study area. The Packed Cell Volume (PCV) of collected blood samples was determined using haematocrit. A total of 50 traps were deployed to study the entomological survey. In general, 2.99 % of the studied cattle were infected with Trypanosomosis and the T.Vivax (58.33%) was the dominant species of trypanosomosis and followed by T. congulense (41.67%) in the study area. Statistically significant differences (P
Zitieren
APA
Adisu, A. (2020). Study on Bovine Trypanosomosis and Associated Risk Factors in Chora District of Oromia Region, Ethiopia. Clinical Research and Clinical Trials. https://doi.org/10.31579/2693-4779/016
Vancouver
Adisu A. Study on Bovine Trypanosomosis and Associated Risk Factors in Chora District of Oromia Region, Ethiopia. Clinical Research and Clinical Trials. 2020. doi:10.31579/2693-4779/016
BibTeX
@article{Adisu2020,
author = {Adisu, Alemitu},
title = {Study on Bovine Trypanosomosis and Associated Risk Factors in Chora District of Oromia Region, Ethiopia},
journal = {Clinical Research and Clinical Trials},
year = {2020},
doi = {10.31579/2693-4779/016}
}
EUVIMED